At the news
? BULLISHIMPACT 7/10 PRESS-RELEASE filed Mar 2, 2026 at 13:00 ET
Smith+Nephew announced its enhanced rotator cuff repair portfolio at the 2026 AAOS Annual Meeting, featuring the Tendon Seam device and REGENETEN Bioinductive Implant, both supported by clinical data and a new AAOS guideline endorsing bioinductive implants. The launch highlights a strategic push to dominate the $6.2B-revenue company's Sports Medicine segment with differentiated technology in a high-failure-rate procedure market.
- Smith+Nephew is showcasing its rotator cuff repair portfolio at AAOS 2026, including the 510(k)-cleared Tendon Seam and REGENETEN Bioinductive Implant.
- AAOS issued a Strong Recommendation supporting bioinductive implants for rotator cuff repair, citing lower re-tear rates and better patient outcomes.
- REGENETEN has been used in over 250,000 procedures globally since 2014, with RCT data showing improved outcomes.
- Tendon Seam offers biomechanical repair with multiple fixation points and integrated instrumentation to simplify surgery.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access